← Leaderboards
Albert A Bowers
Univ Of North Carolina Chapel Hill
$3,755,968
Attributed
$3,962,439
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $609.2K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,962,439 · 2
By mechanism
R35$3,549,497 · 1
R21$412,942 · 1
Top collaborators
- Miriam S. Braunstein2 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Miriam S. Braunstein$8,640,200
- Mary F Paine$16,138,249
- Joseph David Tucker$13,115,535
- Nora Rosenberg$4,362,163
- William Fischer$5,095,957
Others in their field
Other Emerging Leaders on “Anabolism”
- Terry Roemer · Prokaryotics, Inc.$13,565,894
- Robert Nicol · Broad Institute, Inc.$7,498,771
- Zhao Wang · Ut Southwestern Medical Center$5,368,275
- Costas Andreas Lyssiotis · University Of Michigan At Ann Arbor$4,982,483
- Yousong Ding · University Of Florida$4,468,134
- Andrew T Ulijasz · Loyola University Chicago$3,784,401
Research focus
AnabolismEnzymesRibosomesNatural ProductsNovel TherapeuticsMalignant NeoplasmsTechnology DevelopmentInsightScaffoldNatural Products ChemistryPeptidesTherapeutic TargetMessenger RnaPathway InteractionsProteinsBindingComplexPreparationTranscription FactorEvolutionAreaBaseAnalogInhibitor/Antagonist
Grant awards (13)
Chemoenzymatic Synthesis, Mode of Action and Evolution of Natural Product-based Macrocycles$389,341
R35 · FY2025 · GM · contact PI
Chemoenzymatic Synthesis, Mode of Action and Evolution of Natural Product-based Macrocycles$389,341
R35 · FY2024 · GM · contact PI
Chemoenzymatic Synthesis, Mode of Action and Evolution of Natural Product-based Macrocycles$389,341
R35 · FY2023 · GM · contact PI
Chemoenzymatic Synthesis, Mode of Action and Evolution of Natural Product-based Macrocycles$25,496
R35 · FY2023 · GM · contact PI
Chemoenzymatic Synthesis, Mode of Action and Evolution of Natural Product-based Macrocycles$401,511
R35 · FY2022 · GM · contact PI
Chemoenzymatic Synthesis, Mode of Action and Evolution of Natural Product-based Macrocycles$383,398
R35 · FY2021 · GM · contact PI
MIRA Equipment Supplement$37,477
R35 · FY2021 · GM · contact PI
Chemoenzymatic Synthesis, Mode of Action and Evolution of Natural Product-based Macrocycles$383,398
R35 · FY2020 · GM · contact PI
Chemoenzymatic Synthesis, Mode of Action and Evolution of Natural Product-based Macrocycles$383,398
R35 · FY2019 · GM · contact PI
Dual mechanism thiopeptide analogs for TB drug development$225,800
R21 · FY2019 · AI
Chemoenzymatic Synthesis, Mode of Action and Evolution of Natural Product-based Macrocycles$383,398
R35 · FY2018 · GM · contact PI
Dual mechanism thiopeptide analogs for TB drug development$187,142
R21 · FY2018 · AI
Chemoenzymatic Synthesis, Mode of Action and Evolution of Natural Product-based Macrocycles$383,398
R35 · FY2017 · GM · contact PI